Lefèvre T
Institut cardiovasculaire Paris-Sud, hôpital Jacques-Cartier, 6, avenue Noyer-Lambert, 91300 Massy, France.
Ann Cardiol Angeiol (Paris). 2003 Jun;52(3):176-83. doi: 10.1016/s0003-3928(03)00067-2.
Interventional cardiology has evolved tremendously over the past two years with the advent of drug-eluting stents. The RAVEL trial was the first randomized study conducted with sirolimus-eluting stents in a selected population of patients in whom a 0% rate of binary restenosis was achieved. The objective of the SIRIUS trial conducted in a more complex patient population was to test the efficacy of the sirolimus-eluting stent in high-risk settings such as coronary bifurcation lesions.
在过去两年中，随着药物洗脱支架的出现，介入心脏病学取得了巨大的发展。RAVEL试验是第一项针对选定患者群体使用西罗莫司洗脱支架进行的随机研究，该研究实现了0%的二元再狭窄率。在更复杂的患者群体中进行的SIRIUS试验的目的是测试西罗莫司洗脱支架在诸如冠状动脉分叉病变等高风险情况下的疗效。
